ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 191 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $251,255 | +17.4% | 113,178 | +536.8% | 0.12% | +30.9% |
Q3 2021 | $214,000 | -47.8% | 17,773 | -8.4% | 0.09% | -44.4% |
Q2 2021 | $410,000 | -30.9% | 19,398 | -8.3% | 0.17% | -32.4% |
Q1 2021 | $593,000 | +10.8% | 21,157 | +2.8% | 0.25% | +12.6% |
Q4 2020 | $535,000 | +7.0% | 20,576 | +53.1% | 0.22% | -15.3% |
Q3 2020 | $500,000 | -20.9% | 13,442 | +9.2% | 0.26% | -12.4% |
Q2 2020 | $632,000 | +177.2% | 12,310 | +70.1% | 0.30% | +218.1% |
Q1 2020 | $228,000 | -53.9% | 7,235 | -12.8% | 0.09% | +16.0% |
Q4 2019 | $495,000 | +161.9% | 8,298 | +61.3% | 0.08% | +113.2% |
Q3 2019 | $189,000 | -25.3% | 5,144 | -5.3% | 0.04% | -28.3% |
Q2 2019 | $253,000 | +15.0% | 5,430 | -1.0% | 0.05% | -88.7% |
Q1 2019 | $220,000 | -23.9% | 5,483 | -12.7% | 0.47% | +855.1% |
Q4 2018 | $289,000 | -42.3% | 6,279 | -44.4% | 0.05% | -5.8% |
Q3 2018 | $501,000 | -34.4% | 11,297 | -42.0% | 0.05% | -92.3% |
Q2 2018 | $764,000 | -18.4% | 19,484 | +50.5% | 0.68% | -16.9% |
Q1 2018 | $936,000 | +134.6% | 12,943 | +113.7% | 0.81% | +62.1% |
Q4 2017 | $399,000 | -14.0% | 6,057 | -34.5% | 0.50% | +695.2% |
Q3 2017 | $464,000 | +19.3% | 9,250 | +10.1% | 0.06% | +8.6% |
Q2 2017 | $389,000 | -51.6% | 8,404 | -63.1% | 0.06% | -59.4% |
Q1 2017 | $804,000 | +211.6% | 22,773 | +10.6% | 0.14% | +85.7% |
Q4 2016 | $258,000 | +20.0% | 20,590 | +32.5% | 0.08% | -26.0% |
Q3 2016 | $215,000 | +39.6% | 15,540 | 0.0% | 0.10% | -8.8% |
Q2 2016 | $154,000 | -17.2% | 15,540 | +41.1% | 0.11% | -55.5% |
Q1 2016 | $186,000 | – | 11,011 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 1,275,000 | $45,020,000 | 9.84% |
Aviva Holdings Ltd. | 340,100 | $12,009,000 | 5.60% |
Aisling Capital LLC | 837,125 | $29,559,000 | 5.38% |
RA Capital Management | 704,701 | $24,883,000 | 3.05% |
Rhenman & Partners Asset Management AB | 543,347 | $19,186,000 | 3.04% |
BB BIOTECH AG | 1,408,542 | $49,736,000 | 1.63% |
Antipodean Advisors LLC | 91,000 | $3,213,000 | 1.57% |
Iguana Healthcare Management, LLC | 75,000 | $2,648,000 | 1.31% |
Crawford Lake Capital Management, LLC | 93,551 | $3,303,000 | 1.31% |
FT Options LLC | 22,834 | $806,000 | 1.06% |